과제정보
과제창출과 R&D 수행을 제안하고 도와주신 국방과학연구소에 감사드립니다. 또한, 이 작업은 (주)이뮤니스바이오와 국방과학연구소에서 공동으로 수행하였음을 알려드립니다.
참고문헌
- Hu B, Guo H, Zhou P, Shi Z-L, "Characteristics of SARS-COV-2 and COVID-19," Nat Rev Microbiol., United Kingdom, pp. 141-154, 2021.
- She J, Jiang J, Ye L, Hu L, Bai C, Song Y, "2019 novel coronavirus of pneumonia in Wuhan, China: Emerging attack and management strategies," Clin Transl Med., United States, p. 19, 2020.
- Mohan BS, Vinod N, "Covid-19: An insight into SARS-cov2 pandemic originated at Wuhan City in Hubei Province of China," J Infect Dis Epidemiol., United States, p. 146, 2020.
- Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S, "Functions of Natural Killer Cells," Nat Immunol., United Kingdom, pp. 503-10, 2008.
- Lee AJ, Kim SG, Jeon CH, Suh HS, Yoon GS, Seo AN, "A case of natural killer cell leukemia misdiagnosed as tuberculous lymphadenopathy," Korean J Lab Med., Korea, pp. 194-198, 2009.
- Anguille S, Van Acker HH, Van den Bergh J, Willemen Y, Goossens H, Van Tendeloo VF, Smits EL, Berneman ZN, Lion E, "Interleukin-15 Dendritic Cells Harness NK Cell Cytotoxic Effector Function in a Contact- and IL-15-Dependent Manner," PLoS One., United States, e0123340, 2015.
- Carrillo-Bustamante P, Kesmir C, de Boer RJ, "The evolution of natural killer cell receptors," Immunogenetics., Germany, pp. 3-18, 2016.
- Kapur R, Evans DL, Harris DT, "An evolutionary conserved target cell antigen along with MHC class I molecules influences susceptibility to murine NK cell lysis," Dev Comp Immunol., United Kingdom, pp. 347-55, 1995.
- Kumar S, "Natural killer cell cytotoxicity and its regulation by inhibitory receptors," Immunology., United Kingdom, pp. 383-393, 2018.
- Bjorkstrom NK, Strunz B, Ljunggren HG, "Natural killer cells in antiviral immunity," Nat Rev Immunol., United Kingdom, pp. 112-123, 2022.
- Orr MT, Lanier LL, "Natural killer cell education and tolerance," Cell., United States, pp. 847-856, 2010.
- Zwirner NW, Ziblat A, "Regulation of NK Cell Activation and Effector Functions by the IL-12 Family of Cytokines: The Case of IL-27," Front Immunol., Switzerland, 8:25, 2017.
- Mah AY, Cooper MA, "Metabolic Regulation of Natural Killer Cell IFN-γ Production," Crit Rev Immunol., United States, pp. 131-147, 2016.
- Somanchi SS, Senyukov VV, Denman CJ, Lee DA, "Expansion, purification, and functional assessment of human peripheral blood NK cells," J Vis Exp., United States, p. 2540, 2011.
- Nakazawa T, Morimoto T, Maeoka R, Matsuda R, Nakamura M, Nishimura F, Yamada S, Nakagawa I, Park YS, Nakase H, Tsujimura T, "Establishment of an efficient ex vivo expansion strategy for human natural killer cells stimulated by defined cytokine cocktail and antibodies against natural killer cell activating receptors," Regen Ther., Japan, pp. 185-191, 2022.
- Tanaka Y, Nakazawa T, Nakamura M, Nishimura F, Matsuda R, Omoto K, Shida Y, Murakami T, Nakagawa I, Motoyama Y, Morita H, Tsujimura T, Nakase H, "Ex vivo-expanded highly purified natural killer cells in combination with temozolomide induce antitumor effects in human glioblastoma cells in vitro," PLoS One., United States, e0212455, 2019.
- Min B, Choi H, Her JH, Jung MY, Kim H-J, Jung M-young, et al., "Optimization of large-scale expansion and cryopreservation of human natural killer cells for anti-tumor therapy," Immune Network, South Korea, e31, 2018.
- Bae DS, Lee JK, "Development of NK cell expansion methods using feeder cells from human myelogenous leukemia cell line," Blood Res., South Korea, pp. 154-61, 2014.
- Zafarani A, Razizadeh MH, Pashangzadeh S, Amirzarga MRr, Taghavi-Farahabadi M, Mahmoudi M, "Natural killer cells in COVID-19: from infection, to vaccination and therapy," Future Virol., England, 2023.
- Kim H, Byun JE, Yoon SR, Koohy H, Jung H, Choi I, "SARS-CoV-2 peptides bind to NKG2D and increase NK cell activity," Cell Immunol., United States, 104454, 2022.
- Di Vito C, Calcaterra F, Coianiz N, Terzoli S, Voza A, Mikulak J, Della Bella S, Mavilio D, "Natural Killer Cells in SARS-CoV-2 Infection: Pathophysiology and Therapeutic Implications," Front Immunol., Switzerland, 888248, 2022.
- Capuano C, Pighi C, Battella S, De Federicis D, Galandrini R, Palmieri G, Harnessing Cd16-Mediated Nk Cell Functions to Enhance Therapeutic Efficacy of Tumor-Targeting Mabs. Cancers(Basel), Switzerland, 2021.
- Pituch-Noworolska AM, "NK cells in SARS-CoV-2 infection," Cent Eur J Immunol., Poland, pp. 95-101, 2022.
- Wiley SR, Schooley K, Smolak PJ, Din WS, Huang CP, Nicholl JK, et al., Identification and Characterization of a New Member of the Tnf Family That Induces Apoptosis. Immunity, United States, pp. 673-682, 1995.
- Bjorkstrom NK, Riese P, Heuts F, Andersson S, Fauriat C, Ivarsson MA, Bjorklund AT, Tullberg MF, Michaelsson J, Rottenberg ME, Guzman CA, Ljunggren HG, Malmberg KJ, Expression patterns of NKG2A, KIR, and CD57 define a process of CD56dim NK-cell differentiation uncoupled from NK-cell education. Blood, United States, pp. 3853-3864, 2010.
- Zhang H, Penninger JM, Li Y, Zhong N, Slutsky AS, "Angiotensin-converting enzyme 2 (ACE2) as a SARS-CoV-2 receptor: molecular mechanisms and potential therapeutic target," Intensive Care Med., United States, pp. 586-590, 2020.
- Deng X, Terunuma H, Nieda M, "Exploring the Utility of NK Cells in COVID-19," Biomedicines., Switzerland, 1002, 2022.